Ameluz-photodynamic therapy in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in ...
Prior treatment use did not affect the efficacy or safety of topical ruxolitinib cream 1.5% for up to 52 weeks among patients with atopic dermatitis.
While body lotions aren't miracle workers, they do make a difference. "Moisturizing creams and lotions can help minimize the ...
If you’ve started to see changes in your complexion with each passing birthday, you might also have noticed that the skin ...
Researchers compared the efficacy of various treatment modalities for cutaneous squamous cell carcinoma in situ.
With Jakafi's patent cliff looming, Incyte looks to 2025 launches to bulk up revenue by decade's end
Incyte’s blockbuster JAK inhibitor Jakafi has been driving the company’s sales for years now, with this quarter being no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback